Michelle Rodrigues, a federal technology industry executive, has been appointed vice president for government business development at research and development services provider MRIGlobal. She will become part of the company’s executive leadership team as she oversees business development initiatives for both defense and civil health customers, including the departments of Defense, Agriculture and Health and […] More

A National Institutes of Health division has awarded MRIGlobal a potential $ 13.7 million contract to provide evaluation services in support of research initiatives on Mycobacterium tuberculosis. The company said Feb. 1 it will work to analyze Mtb tools and specimen processes for National Institute of Allergy and Infectious Diseases clinical investigations under the Mtb Quality Assessment requirement. […] More

The Defense Threat Reduction Agency has awarded MRIGlobal a five-year, $6.2 million contract to lead a team of scientists from the U.S., Canada and Sweden to create a vaccine for Tularemia, a disease that can be contracted by both humans and animals. MRIGlobal said Wednesday the contract seeks to push forward the new vaccine candidate […] More

MRIGlobal announced last week it has received a new $63 million, 10-year contract from the National Institute of Environmental Health Sciences to provide analytical chemistry for the National Toxicology Program. MRIGlobal will provide chemical procurement, handling and analytical services in toxicology studies through the National Toxicology Program, examining chemicals found in consumer products and the characteristics […] More

KBR has been selected by a Battelle-MRIGlobal partnership to assess project engineering designs and costs for a Department of Energy-funded research and development center for renewable energy technologies. Houston-based KBR said it received a contract from the Alliance for Sustainable Energy to perform evaluation work on biorefinery and biofuel projects at the National Renewable Energy Laboratory.

More

Albany Molecular Research Inc. has secured a potential 10-year, $39.5 million contract renewal to support a National Institutes of Health program that aims to develop medicines for nervous system disorders. AMRI said Tuesday it will continue to provide medicinal chemistry, absorption, distribution, metabolism and excretion services to the Blueprint Neurotherapeutics Network managed by NIH’s National Institute of Neurological Disorders and […] More